Results 61 to 70 of about 26,959 (237)

Echocardiography for transcatheter aortic valve implantation [PDF]

European Journal of Echocardiography, 2009
Transcatheter aortic valve implantation (TAVI) is a new technology that treats severe aortic stenosis. The technology has specific and mandatory technical requirements that must be met to allow safe and successful procedures. The echocardiographic method for diagnosis of aortic stenosis, anatomical case selection, procedural guidance and management of ...
openaire   +2 more sources

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Updates on transcatheter aortic valve replacement: Techniques, complications, outcome, and prognosis

Journal of the Saudi Heart Association, 2018
Transcatheter aortic valve replacement (TAVR) initially emerged as a therapeutic option for high-risk patients with severe aortic stenosis. Advancement in technologies since the first era of TAVRs, experience from previous obstacles, and lessons learned ...
Jarrah Alfadhli, Mohammed Jeraq, Vikas Singh, Claudia Martinez   +3 more
doaj   +1 more source

Atrioventricular conduction after transcatheter aortic valve implantation and surgical aortic valve replacement

, 2012
Atrioventricular conduction abnormalities (AVCA) may complicate transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR).
Windecker, Stephan, Carrel, Thierry, Roten, Laurent, Scarcia, Flavio, Delacrétaz, Etienne, Tanner, Hildegard, Kadner, Alexander, Wenaweser, Peter, Stortecky, Stefan, Meier, Bernhard   +9 more
core   +1 more source

Allegra Transcatheter Heart Valve inside a Degenerated Sutureless Aortic Bioprosthesis

The Thoracic & Cardiovascular Surgeon Reports, 2021
Transcatheter aortic valve-in-valve implantation (VIV) is increasingly being used to successfully treat degenerated surgical aortic valve bioprostheses (SAVs).
Maximilian Vondran, Bernd Abt, Holger Nef, Ardawan J. Rastan   +3 more
doaj   +1 more source

The future of transcatheter aortic valve implantation [PDF]

European Heart Journal, 2015
Since the introduction of transcatheter aortic valve implantation (TAVI) into clinical practice, the treatment of aortic stenosis has changed dramatically. In the past, medical therapy with or without balloon aortic valvuloplasty was the only option for inoperable patients.
Christian W, Hamm, Mani, Arsalan, Michael J, Mack   +2 more
openaire   +2 more sources

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. [PDF]

, 2014
An exponential increase in the use of transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis has been witnessed over the recent years. The current article reviews different areas of uncertainty related to patient selection.
Rodés-Cabau, Josep, Roberts, William C. (William Clifford), Hamm, Christian W., Thomas, Martyn, Hamm, Christian, Erbel, Raimund, Kappetein, Arie P, Zamorano, Jose Luis, Webb, John, Collet, Jean P., Serruys, P. W., Roberts, William C, Vahanian, Alec, Webb, John G. (John Graydon), Pibarot, Philippe, Bax, Jeroen J, Bapat, Vinayak, Windecker, Stephan, Collet, Jean P, Piazza, Nicolo, Leipsic, Jonathon, MacCarthy, Philip, Kappetein, A. P., Delgado, Victoria, Bax, Jeroen J., Zamorano, José L. (José Luis), Baumgartner, Helmut, Leon, Martin B., Leon, Martin B, Serruys, Patrick W   +29 more
core   +1 more source

Transcatheter Heart Valves—An Update on Types of Valves Available, Hardware Characteristics, and Patient Selection: An Indian Perspective

Indian Journal of Clinical Cardiology
Transcatheter aortic valve implantation has taken the world by storm. The past decade saw expanding indications of Transcatheter aortic valve implantation to include patients at low surgical risk for surgical aortic valve replacement, patients with ...
Anoop Agrawal
doaj   +1 more source

Transcatheter aortic valve implantation with SAPIEN 3 versus surgical aortic valve replacement in patients with symptomatic severe aortic stenosis at low risk of surgical mortality: a cost-utility analysis for Switzerland

Swiss Medical Weekly
AIMS OF THE STUDY: The 2021 European Society of Cardiology Guidelines on valvular heart disease recommend transcatheter aortic valve implantation (TAVI) for patients with symptomatic severe aortic stenosis at low surgical risk and age ≥75 years who are ...
Christophe Alain Wyss, Roberto Corti, Thomas Nestelberger, Pascal Candolfi, Alexis Delbaere, Barbara Fischer, Matthias Schwenkglenks, Harry Telser   +7 more
doaj   +1 more source